Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas
- PMID: 20689206
- PMCID: PMC2992926
- DOI: 10.4103/0301-4738.67068
Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas
Abstract
Glaucoma drainage devices are an option in refractory glaucomas for control of intraocular pressure (IOP). We evaluated the outcome of pars plana Ahmed glaucoma valve along with triamcinolone-assisted vitrectomy in 11 eyes with uncontrolled IOP on maximum tolerable antiglaucoma therapy. The mean preoperative IOP of 33.64 +/- 5.99 (range 26 to 44 mmHg) decreased to 17.09 +/- 2.26 (range 14 to 20 mmHg) and 17.45 +/- 1.81 mm of Hg (range 14 to 24 mmHg) at 6 and 12 months following surgery. The mean number of antiglaucoma medications decreased from 3.27 +/- 0.05 to 0.64 +/- 0.67 and 0.55 +/- 0.6 at 6 and 12 months following surgery.
Figures
References
-
- Schlote T, Ziemssen F, Bartz-Schmidt KU. Pars plana-modified Ahmed Glaucoma Valve for treatment of refractory glaucoma: A pilot study. Graefes Arch Clin Exp Ophthalmol. 2006;244:336–41. - PubMed
-
- Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, Riazi-Esfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38:292–300. - PubMed
-
- Shah SK, Vasavada V, Praveen MR, Vasavada AR, Trivedi RH, Dixit NV. Triamcinolone-assisted vitrectomy in pediatric cataract surgery. J Cataract Refract Surg. 2009;35:230–2. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous